ATE443516T1 - Verfahren zur verabreichung eines nasensprays - Google Patents

Verfahren zur verabreichung eines nasensprays

Info

Publication number
ATE443516T1
ATE443516T1 AT05820776T AT05820776T ATE443516T1 AT E443516 T1 ATE443516 T1 AT E443516T1 AT 05820776 T AT05820776 T AT 05820776T AT 05820776 T AT05820776 T AT 05820776T AT E443516 T1 ATE443516 T1 AT E443516T1
Authority
AT
Austria
Prior art keywords
spray
administration
nasal spray
formulation
characteristic
Prior art date
Application number
AT05820776T
Other languages
English (en)
Inventor
Gerald Cagle
G Wall
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE443516T1 publication Critical patent/ATE443516T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007Syringe-type or piston-type sprayers or atomisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • A61M15/0025Mouthpieces therefor with caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/10Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05820776T 2004-11-24 2005-10-31 Verfahren zur verabreichung eines nasensprays ATE443516T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63088604P 2004-11-24 2004-11-24
PCT/US2005/039268 WO2006057769A2 (en) 2004-11-24 2005-10-31 Method of delivering nasal spray

Publications (1)

Publication Number Publication Date
ATE443516T1 true ATE443516T1 (de) 2009-10-15

Family

ID=36498400

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05820776T ATE443516T1 (de) 2004-11-24 2005-10-31 Verfahren zur verabreichung eines nasensprays

Country Status (19)

Country Link
US (3) US20060110328A1 (de)
EP (1) EP1814538B1 (de)
JP (1) JP5068172B2 (de)
KR (1) KR101158603B1 (de)
CN (2) CN103860540A (de)
AT (1) ATE443516T1 (de)
AU (1) AU2005309951B2 (de)
BR (1) BRPI0518283A2 (de)
CA (1) CA2586553C (de)
CY (1) CY1110528T1 (de)
DE (1) DE602005016833D1 (de)
DK (1) DK1814538T3 (de)
ES (1) ES2331619T3 (de)
MX (1) MX2007005845A (de)
PL (1) PL1814538T3 (de)
PT (1) PT1814538E (de)
SI (1) SI1814538T1 (de)
WO (1) WO2006057769A2 (de)
ZA (1) ZA200704139B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6788460B2 (en) 1998-04-15 2004-09-07 Duke University Projection screen apparatus
US6816306B2 (en) 1998-04-15 2004-11-09 Bright View Technologies Inc. Micro-lens array based light transmitting screen with high resolution and low imaging artifacts
US6829087B2 (en) 1998-04-15 2004-12-07 Bright View Technologies, Inc. Micro-lens array based light transmitting screen with tunable gain
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
SI2114367T1 (sl) 2007-02-07 2016-01-29 Novartis Ag Formulacije olopatadina za topično nazalno dajanje
US20110011392A1 (en) 2009-07-17 2011-01-20 Wall G Michael Olopatadine nasal spray regimen for children
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
GB2485604A (en) * 2010-11-22 2012-05-23 Martin Chard Device for marking a surface
US9937189B2 (en) 2013-09-13 2018-04-10 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
EP3718533A1 (de) * 2013-09-13 2020-10-07 Glenmark Specialty S.A. Stabile pharmazeutische zusammensetzung in fester dosierung mit mometason und olopatadin
US9370483B2 (en) 2013-09-13 2016-06-21 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10653661B2 (en) 2013-10-04 2020-05-19 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10016443B2 (en) 2013-10-04 2018-07-10 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10548907B2 (en) 2013-10-04 2020-02-04 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
EP4272839A3 (de) 2013-10-04 2024-01-03 Glenmark Specialty S.A. Behandlung von allergischer rhinitis unter verwendung einer kombination von mometason und olopatadin
CN104063850B (zh) * 2014-06-24 2017-02-01 广东互维科技有限公司 红眼修复方法
US11679210B2 (en) 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN107569454B (zh) * 2017-09-29 2018-05-04 深圳大佛药业股份有限公司 一种盐酸奥洛他定鼻喷雾剂及其制备方法
US11890409B1 (en) * 2019-11-19 2024-02-06 Saeed Rezakhany Methods of curing early stages of, and preventing, upper respiratory infections and applicators therefor
USD969992S1 (en) * 2020-12-23 2022-11-15 Aptar France Sas Device for nasal spray
WO2023167909A2 (en) * 2022-03-02 2023-09-07 Vijay Duggal A hydrogen peroxide-based therapeutic spray for protection and treatment of mucosa

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (de) * 1956-03-21 1900-01-01
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB2208646B (en) * 1987-08-13 1991-06-26 Glaxo Group Ltd Indole derivatives
JPH0323237U (de) * 1989-07-19 1991-03-11
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
FR2803612B1 (fr) * 2000-01-12 2002-12-06 Michel Jean Louis Mar Doustaly Point d'eau sanitaire adaptable a une cuvette de wc
GB0014892D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
IT1317998B1 (it) * 2000-06-26 2003-07-21 Medical Internat Licensing N V Valvola erogatrice per spray nasale.
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US20040235955A1 (en) * 2001-09-14 2004-11-25 Masami Narita Remedies for pruritus
CA2504200A1 (en) * 2002-11-12 2004-05-27 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol

Also Published As

Publication number Publication date
AU2005309951A1 (en) 2006-06-01
KR20070086638A (ko) 2007-08-27
WO2006057769A2 (en) 2006-06-01
DK1814538T3 (da) 2009-11-02
SI1814538T1 (sl) 2010-01-29
US20140227326A1 (en) 2014-08-14
CY1110528T1 (el) 2015-04-29
PT1814538E (pt) 2009-11-10
KR101158603B1 (ko) 2012-07-09
EP1814538A4 (de) 2007-11-07
EP1814538B1 (de) 2009-09-23
AU2005309951B2 (en) 2011-07-07
MX2007005845A (es) 2007-07-04
JP2008521488A (ja) 2008-06-26
ZA200704139B (en) 2008-10-29
EP1814538A2 (de) 2007-08-08
PL1814538T3 (pl) 2010-02-26
BRPI0518283A2 (pt) 2008-11-11
US20060110328A1 (en) 2006-05-25
DE602005016833D1 (de) 2009-11-05
CA2586553C (en) 2015-02-10
JP5068172B2 (ja) 2012-11-07
ES2331619T3 (es) 2010-01-11
CA2586553A1 (en) 2006-06-01
WO2006057769A3 (en) 2006-08-31
CN103860540A (zh) 2014-06-18
CN101065122A (zh) 2007-10-31
US20170172974A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
ATE443516T1 (de) Verfahren zur verabreichung eines nasensprays
JP2008521488A5 (de)
WO2012119153A3 (en) Nasal drug delivery device
CN204170234U (zh) 呼吸内科用喷药器
WO2006014167A3 (en) Face and tracheostomy nebulizing mask
CN203436642U (zh) 雾粒双筛层细药液雾化器
MY137249A (en) Aerosol formulation for inhalation containing a tiotropium salt
CN103432661B (zh) 一次性吸入式药物雾化器
CN209575449U (zh) 一种儿童用雾化器
CN203852680U (zh) 一种医用雾化喷雾装置
CN203417379U (zh) 卧式吸入式药物雾化器
WO2022032468A8 (zh) 抗呼吸道病毒的装置、方法及药物
CN201510614U (zh) 一种新型雾化器
CN203417380U (zh) 新型一次性吸入式药物雾化器
MX2021008082A (es) Dispositivo de administracion de farmaco nasal.
CN203417381U (zh) 细筛雾粒药液雾化器
CN203436641U (zh) 三级雾化药液雾化器
CN203469160U (zh) 立式吸入式药物雾化器
CN204092752U (zh) 一种雾化口罩和雾化装置
CN207856040U (zh) 喷雾疗法雾化机用高弥散扁嘴喷头
CN205494588U (zh) 防脱儿童雾化面罩
CN203469161U (zh) 便于持握的吸入式药物雾化器
CN107485768A (zh) 喷雾疗法雾化机用高弥散扁嘴喷头

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1814538

Country of ref document: EP